{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:01:07Z","timestamp":1790161267080,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100025294","name":"Research Ireland","doi-asserted-by":"publisher","award":["12\/RC\/2275(P2)  and 18\/EPSRC-CDT\/3587"],"award-info":[{"award-number":["12\/RC\/2275(P2)  and 18\/EPSRC-CDT\/3587"]}],"id":[{"id":"10.13039\/501100025294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/S023054\/1"],"award-info":[{"award-number":["EP\/S023054\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Many fertility treatments require regular injections that can impact patients\u2019 everyday lives. Transdermal delivery may reduce the treatment burden, but physical and biochemical barriers of the skin limit the drugs\u2019 bioavailability. Microarray patches (MAPs) present a novel formulation option that helps delivering medicines through the skin. Their administration is perceived to be straightforward and patient-friendly; however, existing acceptability studies have largely focused on MAP-based vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This study aimed to investigate patients\u2019, partners\u2019 and healthcare professionals\u2019 experiences of fertility injections, and to explore their perspectives on potential MAP use and key factors for optimal user acceptance in fertility care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A qualitative interview study was conducted in Ireland between September 2025 and January 2026. Patients, partners and healthcare professionals (including nurses, pharmacists, midwives and consultants) were eligible to participate. Interviewees were recruited by convenience sampling through researchers\u2019 networks, advertisement on social media and targeted outreach to fertility clinics. Semi-structured interviews followed a topic guide. Audio recordings were transcribed verbatim and transcripts analysed using Braun and Clarke\u2019s reflexive thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-two participants (n=10 patients\/n=1 partner, n=11 healthcare professionals) of varying age, professional\/educational background, residential\/practise location, and experience with fertility care were interviewed. Five key themes emerged: (1) The complexity of administration-drug and formulation considerations; (2) The importance of support systems-partners, peers, and healthcare professionals; (3) Managing expectations-medicine information and treatment outcome; (4) Making it work-logistical and lifestyle adjustments; and (5) Education and training-healthcare professionals and patients. Participants highlighted patients\u2019 hopes for treatment success and their resilience to endure practical and emotional challenges like reconstituting injectables, sharps disposal, and fear of mistakes. While MAPs could enhance treatment experiences, they should meet important acceptability criteria including straightforward use, flexible dosing, room temperature storage, minimal pain and skin reactions, comparable efficiency and cost to injectables, and comprehensive counselling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlighted the potential positive impact of MAPs on the unique practical and emotional challenges of fertility patients. The findings will help to inform next steps in exploring MAP-based fertility treatments but also have implications for the development of future fertility injectables.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-026-02220-1","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:00:35Z","timestamp":1790157635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microarray patches as a potential alternative to injectable fertility medications: a qualitative study of patients\u2019 and healthcare professionals\u2019 perceptions"],"prefix":"10.1007","author":[{"given":"Laura","family":"Koenitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abina","family":"Crean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Vucen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"O\u2019Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"2220_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.clinbiochem.2018.03.012","volume":"62","author":"M Vander Borght","year":"2018","unstructured":"Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018;62:2\u201310. https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.03.012.","journal-title":"Clin Biochem"},{"issue":"12","key":"2220_CR2","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1093\/humrep\/dead197","volume":"38","author":"J Smeenk","year":"2019","unstructured":"The European IVF Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE), Smeenk J, Wyns C, De Geyter C,  et al. ART in Europe, 2019: results generated from European registries by ESHRE\u2020. Hum Reprod. 2019;38(12):2321\u201338. https:\/\/doi.org\/10.1093\/humrep\/dead197.","journal-title":"Hum Reprod"},{"issue":"1","key":"2220_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.fertnstert.2025.02.009","volume":"124","author":"GD Adamson","year":"2025","unstructured":"Adamson GD, Creighton P, Mouzon J, et al. How many infants have been born with the help of assisted reproductive technology? Fertil Steril. 2025;124(1):40\u201350. https:\/\/doi.org\/10.1016\/j.fertnstert.2025.02.009.","journal-title":"Fertil Steril"},{"issue":"11","key":"2220_CR4","doi-asserted-by":"publisher","first-page":"237437352412293","DOI":"10.1177\/23743735241229380","volume":"1","author":"B Collura","year":"2024","unstructured":"Collura B, Hayward B, Modrzejewski KA, et al. Identifying factors associated with discontinuation of infertility treatment prior to achieving pregnancy: results of a nationwide survey. J Patient Exp. 2024;1(11):23743735241229380. https:\/\/doi.org\/10.1177\/23743735241229380.","journal-title":"J Patient Exp"},{"issue":"4","key":"2220_CR5","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/oxfordjournals.humrep.a019276","volume":"11","author":"J Boivin","year":"1996","unstructured":"Boivin J, Takefnan JE. Impact of the in-vitro fertilization process on emotional, physical and relational variables*. Hum Reprod. 1996;11(4):903\u20137. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a019276.","journal-title":"Hum Reprod"},{"key":"2220_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.rbms.2019.08.003","volume":"9","author":"P Barri\u00e8re","year":"2019","unstructured":"Barri\u00e8re P, Avril C, Benmahmoud-Zoubir A, et al. Patient perceptions and understanding of treatment instructions for ovarian stimulation during infertility treatment. Reprod Biomed Soc Online. 2019;9:37\u201347. https:\/\/doi.org\/10.1016\/j.rbms.2019.08.003.","journal-title":"Reprod Biomed Soc Online"},{"key":"2220_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1477-7525-11-130","volume":"11","author":"M Brod","year":"2013","unstructured":"Brod M, Fennema H. Validation of the controlled ovarian stimulation impact measure (COSI): assessing the patient perspective. Health Qual Life Outcomes. 2013;11:130. https:\/\/doi.org\/10.1186\/1477-7525-11-130.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"2220_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/s1472-6483(10)60098-3","volume":"18","author":"M Brod","year":"2009","unstructured":"Brod M, Verhaak CM, Wiebinga CJ, et al. Improving clinical understanding of the effect of ovarian stimulation on women\u2019s lives. Reprod Biomed Online. 2009;18(3):391\u2013400. https:\/\/doi.org\/10.1016\/s1472-6483(10)60098-3.","journal-title":"Reprod Biomed Online"},{"issue":"8","key":"2220_CR9","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/humrep\/dew111","volume":"31","author":"K Lankreijer","year":"2016","unstructured":"Lankreijer K, D\u2019Hooghe T, Sermeus W, et al. Development and validation of the FertiMed questionnaire assessing patients\u2019 experiences with hormonal fertility medication. Hum Reprod. 2016;31(8):1799\u2013808. https:\/\/doi.org\/10.1093\/humrep\/dew111.","journal-title":"Hum Reprod"},{"issue":"19","key":"2220_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S1472-6483(10)60271-4","volume":"1","author":"D Huisman","year":"2009","unstructured":"Huisman D, Raymakers X, Hoomans E. Understanding the burden of ovarian stimulation: fertility expert and patient perceptions. Reprod Biomed Online. 2009;1(19):5\u201310. https:\/\/doi.org\/10.1016\/S1472-6483(10)60271-4.","journal-title":"Reprod Biomed Online"},{"key":"2220_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1477-7827-8-111","volume":"8","author":"JT Welcker","year":"2010","unstructured":"Welcker JT, Nawroth F, Bilger W. Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study. Reprod Biol Endocrinol. 2010;8:111. https:\/\/doi.org\/10.1186\/1477-7827-8-111.","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"2220_CR12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/humrep\/der449","volume":"27","author":"E Landfeldt","year":"2012","unstructured":"Landfeldt E, Jablonowska B, Norlander E, et al. Patient preferences for characteristics differentiating ovarian stimulation treatments. Hum Reprod. 2012;27(3):760\u20139. https:\/\/doi.org\/10.1093\/humrep\/der449.","journal-title":"Hum Reprod"},{"issue":"4","key":"2220_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.6061\/clinics\/2014(04)10","volume":"69","author":"RdeBF Le\u00e3o","year":"2014","unstructured":"Le\u00e3o RdeBF, Esteves SC. Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech. Clinics (Sao Paulo). 2014;69(4):279\u201393. https:\/\/doi.org\/10.6061\/clinics\/2014(04)10.","journal-title":"Clinics (Sao Paulo)"},{"issue":"12","key":"2220_CR14","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.1016\/j.apsb.2025.10.026","volume":"15","author":"M Liu","year":"2025","unstructured":"Liu M, Svirskis D, Proft T, et al. Progress in peptide and protein therapeutics: challenges and strategies. Acta Pharm Sin B. 2025;15(12):6342\u201381. https:\/\/doi.org\/10.1016\/j.apsb.2025.10.026.","journal-title":"Acta Pharm Sin B"},{"key":"2220_CR15","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.csbj.2019.09.004","volume":"17","author":"R Bajracharya","year":"2019","unstructured":"Bajracharya R, Song JG, Back SY, et al. Recent advancements in non-invasive formulations for protein drug delivery. Comput Struct Biotechnol J. 2019;17:1290\u2013308. https:\/\/doi.org\/10.1016\/j.csbj.2019.09.004.","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"2220_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11095-010-0101-2","volume":"28","author":"JC Birchall","year":"2011","unstructured":"Birchall JC, Clemo R, Anstey A, et al. Microneedles in clinical practice\u2013an exploratory study into the opinions of healthcare professionals and the public. Pharm Res. 2011;28(1):95\u2013106. https:\/\/doi.org\/10.1007\/s11095-010-0101-2.","journal-title":"Pharm Res"},{"key":"2220_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.02.040","volume":"128","author":"J Arya","year":"2017","unstructured":"Arya J, Henry S, Kalluri H, et al. Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects. Biomaterials. 2017;128:1\u20137. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.02.040.","journal-title":"Biomaterials"},{"issue":"3","key":"2220_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003024","volume":"17","author":"AH Forster","year":"2020","unstructured":"Forster AH, Witham K, Depelsenaire ACI, et al. Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: results from a randomized, controlled phase I clinical trial. PLoS Med. 2020;17(3):e1003024. https:\/\/doi.org\/10.1371\/journal.pmed.1003024.","journal-title":"PLoS Med"},{"key":"2220_CR19","doi-asserted-by":"publisher","first-page":"125874","DOI":"10.1016\/j.ijpharm.2025.125874","volume":"682","author":"D Sanjanwala","year":"2025","unstructured":"Sanjanwala D, Shinde A, Patravale V. Formulation, sterilization, and clinical evaluation of microneedles for vaccine and biologic delivery: a review. Int J Pharm. 2025;682:125874. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125874.","journal-title":"Int J Pharm"},{"issue":"1","key":"2220_CR20","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-025-03246-w","volume":"27","author":"K Gopal","year":"2025","unstructured":"Gopal K, Khalid R, Mahmood S. Dissolvable microneedles with their design, materials, and limitations in translation: a technical review. AAPS PharmSciTech. 2025;27(1):13. https:\/\/doi.org\/10.1208\/s12249-025-03246-w.","journal-title":"AAPS PharmSciTech"},{"issue":"37","key":"2220_CR21","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1016\/j.vaccine.2017.07.083","volume":"35","author":"S Marshall","year":"2017","unstructured":"Marshall S, Fleming A, Moore AC, et al. Acceptability of microneedle-patch vaccines: a qualitative analysis of the opinions of parents. Vaccine. 2017;35(37):4896\u2013904. https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.083.","journal-title":"Vaccine"},{"issue":"45","key":"2220_CR22","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.1016\/j.vaccine.2020.07.064","volume":"38","author":"PM Frew","year":"2020","unstructured":"Frew PM, Paine MB, Rouphael N, et al. Acceptability of an inactivated influenza vaccine delivered by microneedle patch: results from a phase I clinical trial of safety, reactogenicity, and immunogenicity. Vaccine. 2020;38(45):7175\u201381. https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.064.","journal-title":"Vaccine"},{"issue":"37","key":"2220_CR23","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1016\/j.vaccine.2015.03.062","volume":"33","author":"E Jacoby","year":"2015","unstructured":"Jacoby E, Jarrahian C, Hull HF, et al. Opportunities and challenges in delivering influenza vaccine by microneedle patch. Vaccine. 2015;33(37):4699\u2013704. https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.062.","journal-title":"Vaccine"},{"key":"2220_CR24","doi-asserted-by":"publisher","unstructured":"Griffin P, Elliott S, Krauer K, et al. Safety, acceptability and tolerability of uncoated and excipient-coated high density silicon micro-projection array patches in human subjects. Vaccine. 2017 4;35(48, Part B):6676\u201384. https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.021","DOI":"10.1016\/j.vaccine.2017.10.021"},{"issue":"26","key":"2220_CR25","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1016\/j.vaccine.2018.05.053","volume":"36","author":"GJP Fernando","year":"2018","unstructured":"Fernando GJP, Hickling J, Jayashi Flores CM, et al. Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch\u2122). Vaccine. 2018;36(26):3779\u201388. https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.053.","journal-title":"Vaccine"},{"issue":"6","key":"2220_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/ijpp.12195","volume":"23","author":"K Mooney","year":"2015","unstructured":"Mooney K, McElnay JC, Donnelly RF. Parents\u2019 perceptions of microneedle-mediated monitoring as an alternative to blood sampling in the monitoring of their infants. Int J Pharm Pract. 2015;23(6):429\u201338. https:\/\/doi.org\/10.1111\/ijpp.12195.","journal-title":"Int J Pharm Pract"},{"issue":"4","key":"2220_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s13346-015-0223-5","volume":"5","author":"K Mooney","year":"2015","unstructured":"Mooney K, McElnay JC, Donnelly RF. Paediatricians\u2019 opinions of microneedle-mediated monitoring: a key stage in the translation of microneedle technology from laboratory into clinical practice. Drug Deliv Transl Res. 2015;5(4):346\u201359. https:\/\/doi.org\/10.1007\/s13346-015-0223-5.","journal-title":"Drug Deliv Transl Res"},{"issue":"6","key":"2220_CR28","doi-asserted-by":"publisher","first-page":"1351692","DOI":"10.3389\/frph.2024.1351692PubMedPMID:38515793;PubMedCentralPMCID:PMC10954799","volume":"7","author":"M El-Sahn","year":"2024","unstructured":"El-Sahn M, Elliott R, El-Sahn M, et al. End-user research into understanding perceptions of and reactions to a microarray patch (MAP) for contraception among women in Ghana, Kenya and Uganda. Front Reprod Health. 2024;7(6):1351692. https:\/\/doi.org\/10.3389\/frph.2024.1351692PubMedPMID:38515793;PubMedCentralPMCID:PMC10954799.","journal-title":"Front Reprod Health"},{"issue":"2","key":"2220_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s13346-017-0393-4","volume":"8","author":"HL Quinn","year":"2018","unstructured":"Quinn HL, Hughes CM, Donnelly RF. In vivo and qualitative studies investigating the translational potential of microneedles for use in the older population. Drug Deliv Transl Res. 2018;8(2):307\u201316. https:\/\/doi.org\/10.1007\/s13346-017-0393-4.","journal-title":"Drug Deliv Transl Res"},{"key":"2220_CR30","doi-asserted-by":"publisher","first-page":"1125159","DOI":"10.3389\/frph.2023.1125159","volume":"5","author":"SG Gachigua","year":"2023","unstructured":"Gachigua SG, Karuga R, Ngunjiri A, et al. Microarray patch for HIV prevention and as a multipurpose prevention technology to prevent HIV and unplanned pregnancy: an assessment of potential acceptability, usability, and programmatic fit in Kenya. Front Reprod Health. 2023;5:1125159. https:\/\/doi.org\/10.3389\/frph.2023.1125159.","journal-title":"Front Reprod Health"},{"issue":"6","key":"2220_CR31","doi-asserted-by":"publisher","first-page":"e0216797","DOI":"10.1371\/journal.pone.0216797","volume":"14","author":"A Brunie","year":"2019","unstructured":"Brunie A, Callahan RL, Godwin CL. User preferences for a contraceptive microarray patch in India and Nigeria: qualitative research on what women want. PLoS ONE. 2019;14(6):e0216797. https:\/\/doi.org\/10.1371\/journal.pone.0216797.","journal-title":"PLoS ONE"},{"issue":"6","key":"2220_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042.","journal-title":"Int J Qual Health Care"},{"key":"2220_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.114523","volume":"292","author":"M Hennink","year":"2022","unstructured":"Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: a systematic review of empirical tests. Soc Sci Med. 2022;292:114523. https:\/\/doi.org\/10.1016\/j.socscimed.2021.114523.","journal-title":"Soc Sci Med"},{"issue":"2","key":"2220_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qual Res Psychol"},{"key":"2220_CR35","unstructured":"Lumivero. 2026; NVivo (Version 15.5.2) [Computer software, RRID SCR_014802]. https:\/\/lumivero.com\/products\/nvivo\/"},{"issue":"6","key":"2220_CR36","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1177\/1363459310364161","volume":"15","author":"S Silva","year":"2011","unstructured":"Silva S, Machado H. Heterosexual couples\u2019 uses and meanings of ovarian stimulation: relatedness, embodiment and emotions. Health (N Y). 2011;15(6):620\u201332. https:\/\/doi.org\/10.1177\/1363459310364161.","journal-title":"Health (N Y)"},{"issue":"1","key":"2220_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-018-0753-2","volume":"19","author":"K Ellis","year":"2018","unstructured":"Ellis K, Mulnier H, Forbes A. Perceptions of insulin use in type 2 diabetes in primary care: a thematic synthesis. BMC Fam Pract. 2018;19(1):70. https:\/\/doi.org\/10.1186\/s12875-018-0753-2.","journal-title":"BMC Fam Pract"},{"issue":"1","key":"2220_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-14-164","volume":"14","author":"H Abu Hassan","year":"2013","unstructured":"Abu Hassan H, Tohid H, Mohd Amin R, et al. Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration. BMC Fam Pract. 2013;14(1):164. https:\/\/doi.org\/10.1186\/1471-2296-14-164.","journal-title":"BMC Fam Pract"},{"issue":"4","key":"2220_CR39","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/24755303241253200","volume":"9","author":"M Zaino","year":"2024","unstructured":"Zaino M, Parks E, McNeil J, et al. Patients\u2019 preferences regarding modes of systemic psoriasis treatment \u2013 a qualitative study. J Psoriasis Psoriatic Arthritis. 2024;9(4):136\u201342. https:\/\/doi.org\/10.1177\/24755303241253200.","journal-title":"J Psoriasis Psoriatic Arthritis"},{"issue":"5","key":"2220_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/pharmacy11050133","volume":"11","author":"M Puzovic","year":"2023","unstructured":"Puzovic M, Morrissey H, Ball PA. The Experience of Home Parenteral Therapy: A Thematic Analysis of Patient Interviews. Pharmacy. 2023;11(5):133. https:\/\/doi.org\/10.3390\/pharmacy11050133.","journal-title":"Pharmacy"},{"key":"2220_CR41","doi-asserted-by":"publisher","unstructured":"Capelle A de C van, Meide H van der, Vosman FJH et al., A qualitative study assessing patient perspectives in the process of decision-making on disease modifying therapies (DMT\u2019s) in multiple sclerosis (MS). PLOS ONE. 2017 12(8): e0182806. https:\/\/doi.org\/10.1371\/journal.pone.0182806","DOI":"10.1371\/journal.pone.0182806"},{"issue":"5","key":"2220_CR42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/ijpp.12081","volume":"22","author":"K Mooney","year":"2014","unstructured":"Mooney K, McElnay JC, Donnelly RF. Children&s views on microneedle use as an alternative to blood sampling for patient monitoring. Int J Pharm Pract. 2014;22(5):335\u201344. https:\/\/doi.org\/10.1111\/ijpp.12081.","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"2220_CR43","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ijpharm.2015.04.076","volume":"489","author":"E Caffarel-Salvador","year":"2015","unstructured":"Caffarel-Salvador E, Tuan-Mahmood TM, McElnay JC, et al. Potential of hydrogel-forming and dissolving microneedles for use in paediatric populations. Int J Pharm. 2015;489(1):158\u201369. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.04.076.","journal-title":"Int J Pharm"},{"issue":"9","key":"2220_CR44","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1093\/humrep\/der177","volume":"26","author":"AM Musters","year":"2011","unstructured":"Musters AM, de Bekker-Grob EW, Mochtar MH, et al. Women\u2019s perspectives regarding subcutaneous injections, costs and live birth rates in IVF. Hum Reprod. 2011;26(9):2425\u201331. https:\/\/doi.org\/10.1093\/humrep\/der177.","journal-title":"Hum Reprod"},{"issue":"7","key":"2220_CR45","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/humrep\/der139","volume":"26","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, De La Fuente P, Rodr\u00edguez M, et al. Willingness to pay and conjoint analysis to determine women\u2019s preferences for ovarian stimulating hormones in the treatment of infertility in Spain. Hum Reprod. 2011;26(7):1790\u20138. https:\/\/doi.org\/10.1093\/humrep\/der139.","journal-title":"Hum Reprod"},{"issue":"2","key":"2220_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/humrep\/deu307","volume":"30","author":"L van den Wijngaard","year":"2015","unstructured":"van den Wijngaard L, Rodijk ICM, van der Veen F, et al. Patient preference for a long-acting recombinant FSH product in ovarian hyperstimulation in IVF: a discrete choice experiment. Hum Reprod. 2015;30(2):331\u20137. https:\/\/doi.org\/10.1093\/humrep\/deu307.","journal-title":"Hum Reprod"},{"issue":"3","key":"2220_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/humupd\/dmae001","volume":"30","author":"F Von Estorff","year":"2024","unstructured":"Von Estorff F, Mochtar MH, Van Lehmann V, et al. Driving factors in treatment decision-making of patients seeking medical assistance for infertility: a systematic review. Hum Reprod Update. 2024;30(3):341\u201354. https:\/\/doi.org\/10.1093\/humupd\/dmae001.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"2220_CR48","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s40271-021-00563-7","volume":"15","author":"C Skedgel","year":"2022","unstructured":"Skedgel C, Ralphs E, Finn E, et al. How do people with experience of infertility value different aspects of assistive reproductive therapy? Results from a multi-country discrete choice experiment. Patient Patient-Centered Outcomes Res. 2022;15(4):459\u201372. https:\/\/doi.org\/10.1007\/s40271-021-00563-7.","journal-title":"Patient Patient-Centered Outcomes Res"},{"issue":"4","key":"2220_CR49","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/hae.70314","volume":"32","author":"N Bhatt","year":"2026","unstructured":"Bhatt N, Anderson T, Bryndziar T, et al. Perceptions and recommendations regarding haemophilia B gene therapy: a multistakeholder view from patients, caregivers and healthcare professionals. Haemophilia. 2026;32(4):960\u201373. https:\/\/doi.org\/10.1111\/hae.70314.","journal-title":"Haemophilia"},{"issue":"1","key":"2220_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/hae.14908","volume":"30","author":"G Pietu","year":"2024","unstructured":"Pietu G, Giraud N, Chamouard V, et al. Perspectives and perception of haemophilia gene therapy by French patients. Haemophilia. 2024;30(1):68\u201374. https:\/\/doi.org\/10.1111\/hae.14908.","journal-title":"Haemophilia"},{"issue":"5","key":"2220_CR51","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/bcpt.13719","volume":"130","author":"M Varma","year":"2022","unstructured":"Varma M, Almarsd\u00f3ttir AB, Druedahl LC. \u201cBiosimilar, so it looks alike, but what does it mean?\u201d A qualitative study of Danish patients\u2019 perceptions of biosimilars. Basic Clin Pharmacol Toxicol. 2022;130(5):581\u201391. https:\/\/doi.org\/10.1111\/bcpt.13719.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"2220_CR52","first-page":"129","volume":"6","author":"D Press","year":"2008","unstructured":"Press D. Understanding compliance issues for daily self-injectable treatment in ambulatory care settings. Patient Prefer Adherence. 2008;6(2):129\u201336.","journal-title":"Patient Prefer Adherence"},{"key":"2220_CR53","doi-asserted-by":"publisher","DOI":"10.4102\/hsag.v28i0.2359","volume":"28","author":"FN Ndara","year":"2023","unstructured":"Ndara FN, Nuuyoma V. Patients\u2019 lived experiences of self-injectable diabetes treatment: a phenomenological study. Health SA Gesondheid. 2023;28:2359. https:\/\/doi.org\/10.4102\/hsag.v28i0.2359.","journal-title":"Health SA Gesondheid"},{"issue":"6","key":"2220_CR54","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.pcd.2023.08.006","volume":"17","author":"W Liang","year":"2023","unstructured":"Liang W, Lo SHS, Chow KM, et al. Perception of self-management and glycaemic control in people with type 2 diabetes receiving insulin injection therapy: a qualitative study. Prim Care Diabetes. 2023;17(6):587\u201394. https:\/\/doi.org\/10.1016\/j.pcd.2023.08.006.","journal-title":"Prim Care Diabetes"},{"key":"2220_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1477313","volume":"12","author":"F Scholz","year":"2024","unstructured":"Scholz F, B\u00f6rner N, Schust SA, et al. Focus on patient perspectives in climate action policies for healthcare. A German survey analysis on what patients are willing to do. Front Public Health. 2024;12:1477313. https:\/\/doi.org\/10.3389\/fpubh.2024.1477313.","journal-title":"Front Public Health"},{"issue":"3","key":"2220_CR56","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/fampra\/cmad003","volume":"40","author":"J Legrand","year":"2023","unstructured":"Legrand J, Aubin-Auger I, De Bary L, et al. Sustainable development in general practice. Fam Pract. 2023;40(3):511\u20138. https:\/\/doi.org\/10.1093\/fampra\/cmad003.","journal-title":"Fam Pract"},{"issue":"12","key":"2220_CR57","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1177\/00031348251346528","volume":"91","author":"SE Beckwith","year":"2025","unstructured":"Beckwith SE, Petit HJ, Sullivan EE, et al. Patient perceptions about the environmental impact of hospitals and surgical care. Am Surg. 2025;91(12):2090\u20135. https:\/\/doi.org\/10.1177\/00031348251346528.","journal-title":"Am Surg"},{"issue":"3","key":"2220_CR58","doi-asserted-by":"publisher","first-page":"e250159","DOI":"10.57264\/cer-2025-0159PubMedPMID:41705997;PubMedCentralPMCID:PMC12976645","volume":"15","author":"T Tahta","year":"2026","unstructured":"Tahta T, Kaya Y, Tokg\u00f6z VY, et al. The effect of infertility support education on treatment outcomes in women with unexplained infertility. J Comp Eff Res. 2026;15(3):e250159. https:\/\/doi.org\/10.57264\/cer-2025-0159PubMedPMID:41705997;PubMedCentralPMCID:PMC12976645.","journal-title":"J Comp Eff Res"},{"key":"2220_CR59","doi-asserted-by":"publisher","unstructured":"Wyns C, Blockeel C, Guivarc\u2019h-L\u00e9v\u00eaque A, et al. Current practices and challenges in assisted reproductive technology care pathways in France and Belgium: the AMPLITUDE survey. Front Reprod Health. 2025 30;7:1617628. https:\/\/doi.org\/10.3389\/frph.2025.1617628","DOI":"10.3389\/frph.2025.1617628"},{"issue":"6","key":"2220_CR60","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.fertnstert.2018.02.130","volume":"109","author":"AD Domar","year":"2018","unstructured":"Domar AD, Rooney K, Hacker MR, Sakkas D, Dodge LE. Burden of care is the primary reason why insured women terminate in vitro fertilization treatment. Fertil Steril. 2018;109(6):1121\u20136. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.02.130.","journal-title":"Fertil Steril"},{"key":"2220_CR61","unstructured":"World Health Organization. Guideline for the prevention, diagnosis and treatment of infertility [Internet]. Geneva; 2025 [cited 2026 Jul 27]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240115774"},{"issue":"3","key":"2220_CR62","first-page":"237","volume":"19","author":"S Petch","year":"2025","unstructured":"Petch S, O\u2019Byrne L, Hartigan L, et al. National Clinical Practice: Guideline In Vitro Fertilisation (IVF) and Intracytoplasmic Sperm Injection (ICSI). Nat Women Infants Health Progr Inst Obstet Gynaecol. 2025;19(3):237\u201348.","journal-title":"Nat Women Infants Health Progr Inst Obstet Gynaecol."},{"issue":"2","key":"2220_CR63","doi-asserted-by":"publisher","first-page":"105217","DOI":"10.1016\/j.rbmo.2025.105217","volume":"52","author":"R Sylvest","year":"2026","unstructured":"Sylvest R, Schmidt L, Pinborg A, et al. Emotional experience of Danish men during fertility treatment: qualitative study on engagement, hope and loss. Reprod Biomed Online. 2026;52(2):105217. https:\/\/doi.org\/10.1016\/j.rbmo.2025.105217.","journal-title":"Reprod Biomed Online"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02220-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02220-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02220-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:00:39Z","timestamp":1790157639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-026-02220-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":63,"alternative-id":["2220"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02220-1","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to declare.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed written consent was obtained from all participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Social Research Ethics Committee of University College Cork (reference number: 2025-109, date of approval: 27th June 2025).","order":3,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}